SYLA Technologies Announces FY2024 Financial Guidance and Upward Revision of FY2023 Dividend Forecast
Company expects FY2024 revenues to grow by 22.2% to 33.3%compared to 22.5 billion forecasted for FY2023 TOKYO, Jan. 25, 2024 […]
MKS Instruments Selected as a 2024 Campus Forward Award Winner by RippleMatch
ANDOVER, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) — MKS Instruments, a global provider of technologies that transform our world, was […]
Celularity and Genting Leaders Comments on Closing $21 Million Financing Transactions
FLORHAM PARK, N.J., Jan. 25, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (the “Company), a biotechnology company developing allogeneic […]
LPL Financial Welcomes Advisor Andrew Kutanovski
SAN DIEGO, Jan. 25, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) announced today that financial advisor Andrew Kutanovski, CFP®, has […]
HOT WINGS MEET HARD SELTZER! TRULY HARD SELTZER SPICES UP GAME DAY WITH FIRST-EVER HOT WING-INSPIRED SELTZER
BOSTON, Jan. 25, 2024 (GLOBE NEWSWIRE) — Sure, there’s a big football game, flashy commercials, and a much-anticipated halftime show […]
Castellum Announces Pricing of $2.7 Million Registered Direct Offering
BETHESDA, Md., Jan. 25, 2024 (GLOBE NEWSWIRE) — Castellum, Inc. (the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software […]
TELUS report reveals majority of Canadians want regulation and ethics to guide the future of AI
TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) — Today, as the world marks Data Privacy Week, TELUS is proud to highlight […]
Bright Green Corporation announces the agreement to acquire platform technologies and associated intellectual property from C2 Wellness Corp.
Grants, New Mexico, Jan. 25, 2024 (GLOBE NEWSWIRE) — Bright Green Corporation (NASDAQ: BGXX) today announced the agreement to purchase […]
PodcastOne Renews Agreement with The Adam Carolla Podcast and The Adam and Dr. Drew Show
Podcasts Combine for Over 700 Million Downloads and Over 7000 Episodes Carolla Set for Induction into the Podcast Hall of […]
SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference
NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a […]
